StockDrifts LogoStockDrifts

SR Biotech 270210

Company
에스알바이오텍SR Biotech
Insiders
0
Buys
0
Total Value
—
Avg Return
—
Last Filing
2025-07-29

SR Biotech (270210) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for SR Biotech is dated 2024-06-24; the most recent is 2025-07-29. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2025-07-29BUY주식매수청구권 행사
김아리
Ari Kim
Internal director8.1K₩26,950-7.2%₩217M ($151K)
2024-06-24SELL장외매도
비보존
non-preservation
--244.8K₩6,200-303.2%₩1.5B ($1.1M)
2024-06-24BUY장외매수
비에이파트너스
BA Partners
-244.8K₩6,200+303.2%₩1.5B ($1.1M)
2024-06-24BUY제3자배정유상증자
비에이파트너스
BA Partners
-45.7K₩6,200+303.2%₩283M ($197K)

Frequently asked questions

Who has been buying SR Biotech stock?
0 distinct insiders have filed 0 disclosed insider purchases in SR Biotech (270210), most recently on 2025-07-29. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does SR Biotech have?
SR Biotech has 0 buy-side and 0 sell-side disclosures on record, spanning 2024-06-24 to 2025-07-29.
Where does StockDrifts get SR Biotech insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for SR Biotech. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.